Skip to main content
Caplight Logo









Onyx Bio

Onyx Bio

Private
Berkeley, CaliforniaHealthcare & Life Scienceshttps://onyx.bio/

Last Round

Seed

Feb 26, 2026

Momentum

Top 25%

of companies Caplight tracks

Company Overview

Onyx Bio is a biotechnology company that builds a virtual immune system to accelerate and de-risk the development of precision medicines by integrating multiomics data with longitudinal patient records.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Precision Medicine, Medical AI

Business Model

B2B

Customer Profile

Data as a Service, Services & Consulting

AI Layer

Application

Keywords

multi-omicsprecision medicinebiomarker discoverydrug discoverycomputational biologypatient stratificationdigital twinclinical research platformdata as a serviceDaaSlongitudinal studyAI-driven biologybioinformaticsEHR integrationvirtual immune system

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Onyx Bio Comparables

Compare Onyx Bio with similar companies based on industry and business-model similarity.

Onyx Bio comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Scipher Medicine
76%
Immunai
76%
Insitro
71%

Onyx Bio Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedFeb 26, 2026

Key People

Founding team and executive leadership

Amit Lakhani

Co-Founder CTO

Founding Team

Onyx Bio Investors

Notable investors and investment history

Onyx Bio investors
InvestorRounds
Refactor CapitalSeed
HaystackSeed
Robot VenturesSeed
Dimension CapitalSeed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 27, 2026

    Grew 50% QoQ, from 6 to 9 employees.

  • Jul 25, 2026

    Monthly visitors increased 32% MoM.

Onyx Bio Filings

Explore SEC and related filing metadata, where available.

Onyx Bio filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Onyx Bio's valuation, stock price, and market status.

Is Onyx Bio a public or private company?

Onyx Bio is a private company.

What is the current stock price of Onyx Bio?

Onyx Bio is a private company with no public stock price. No recent secondary market data is available.

How much is Onyx Bio worth (valuation)?

Valuation information for Onyx Bio is not publicly available.

Can I buy Onyx Bio stock?

Onyx Bio shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Onyx Bio's last funding round?

Onyx Bio's most recent funding round was Seed Round on February 26, 2026.

Who are the main investors in Onyx Bio?

Key investors in Onyx Bio include Khosla Ventures, First Round Capital.

Will Onyx Bio IPO soon?

No public IPO plans have been announced for Onyx Bio.

How can I track Onyx Bio secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Onyx Bio's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersBerkeley, California
Employee Range9
Year Founded2024
Last FundingFeb 26, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?